News on clinical chemistry systems and applications.
The expanded clearance includes use of the test to assess a patient's risk of developing diabetes. The assay was cleared to run on the Afinion AS100 Analyzer.
Clinicians were surprised by a recent NEJM study that found that using procalcitonin assays did not reduce the use of antibiotics.
The study found that for some patients the standard practice of performing a second confirmatory blood test is not necessary, which could streamline care.
The partners will further develop a test to guide clinical care of patients with Plasmodium vivax malaria who may also have G6PD deficiency.
Patia will offer the assay, which uses mass spectrometry to measure proteins to predict risk of diabetic kidney disease, as a laboratory-developed test.
